We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Indoor health: background levels of fungi.
There is no uniformity in the suggested guidelines for acceptable levels of fungi in indoor ambient air. Thus, health professionals have no way to determine what levels of fungi may pose a threat to human health. The authors reviewed the published literature to identify data reported for noncomplaint structures, that is, structures in which occupants did not have health concerns associated with the quality of the indoor air. For both commercial and residential structures, fungal concentrations detected were often higher than currently suggested guidance values. The average indoor air concentration in 149 noncomplaint commercial buildings was 233 colony forming units (CFU) per cubic meter, whereas outdoor ambient air levels averaged 983 CFU/m(3). Total indoor spore counts ranged from 610 to 1040 spores/m(3) in three commercial buildings. Outdoor total spore counts associated with these buildings ranged from 400 to 80,000 spores/m(3). The average indoor concentration reported for 820 noncomplaint residential structures was 1252 CFU/m(3) with an average outdoor level of 1524 CFU/m(3). Total spore counts detected indoors at 85 residential structures ranged from 68 to 2307 spores/m(3). Outdoor spore levels associated with these structures ranged from 400 to 80,000 spores/m(3). A large proportion of both commercial and residential noncomplaint structures have indoor ambient air fungal concentrations above 500 CFU/m(3), a level often advocated as requiring remediation in structures when occupants complain of nonspecific adverse health symptoms.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app